|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Auxilium Pharmaceuticals Inc - SWOT Analysis |
|
|
|
|
€ 100,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Mars 2008 |
Taille du document : |
23 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Combinatorics IRCD
pages | Juillet 2001 |
Identified by The Economist (*) as the industry to watch for 1997 in the chemicals sector, Combinatorics (also known as combinatorial chemistry) is an emerging platform technology that uses test t |
1 200,00 €
|
| |
| |
03-018: Market Opportunities in Cytokine & Growth Factor Research
170 pages | Mai 2003 |
This report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays |
800,00 €
|
| |
| |
Revolutionise Drug Discovery through Genomics & Proteomics Study
10 pages | Novembre 2002 |
Genomics and Proteomics are complementary technologies of biological research.
The potential of these technologies for biomedical revolution will be realized by integrating them into the drug disc |
200,00 €
|
| |
| |
03-019: The Market for Microbial Genotyping Products: Research and Testing Applications
183 pages | Juin 2003 |
The report identifies the kits, reagents and instrumentation that are most commonly used for microbial identification and analysis in both the research and testing arenas |
800,00 €
|
| |
| |
03-026: The Market for Tissue Microarrays
134 pages | Juillet 2003 |
This report provides vital information on end-users’ scientific objectives, instrumentation for production and analysis of TMAs, outsourcing practices and preferred TMA suppliers |
640,00 €
|
| |
| |
03-054: Immunohistochemistry Market Benchmarking Survey
90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a |
680,00 €
|
| |
| |
Nanotechnology: Emerging Trends
30 pages | Avril 2003 |
Recently, nanotechnology has become extremely popular and is used to describe many types of research where the characteristic dimensions are less than about 1,000 nanometers.
Nanotechnology also pr |
550,00 €
|
| |
| |
Human Genome: Its future
20 pages | Avril 2003 |
Genetic testing interests the companies and the government alike.
Companies are racing to understand and tap the mass of information pouring out of the Human Genome Project.
It is raising hopes |
400,00 €
|
| |
| |
Integrating Genomics: The Next Generation
124 pages | Février 1999 |
Genomics research : Understand the key technologies including target identification (genome mapping, random sequencing and two-hybrid assay), target validation/assay development and current appli |
795,00 €
|
| |
| |
Outsourcing in the Biotech Indsutry
20 pages | Juillet 2002 |
Outsourcing is revolutionising the biotech industry.
Companies have realised that with outsourcing, they can utilise their synergies and work together to deliver products at a faster rate.
The e |
400,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Auxilium Pharmaceuticals Inc - SWOT Analysis |
|
|
Datamonitor's Auxilium Pharmaceuticals Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Auxilium Pharmaceuticals (Auxilium) is a specialty biopharmaceutical company engaged in developing and marketing products in the areas of urology, endocrinology and orthopedics. The company markets Testim, a testosterone replacement treatment for hypogonadism. The company markets its products to urologists, endocrinologists, orthopedists and select primary care physicians. It is headquartered in Malvern, Pennsylvania and employs 269 people as of December 2006. The company recorded revenues of $95.7* million during the fiscal year ended December 2007, an increase of 39.8% over 2006. The operating loss of the company was $44.4 million during fiscal year 2007, compared to an operating loss of $48.4 million in 2006. The net loss was $40.7 million in fiscal year 2007, compared to a net loss of $45.9 million in 2006. *Financials are unaudited http://ir.auxilium.com/phoenix.zhtml?c=142125&p=irol-newsArticle&ID=1108204&highlight=
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
Table of Contents:
This product typically includes the following sections:
Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis
|
|
|
PPLSEN
|
|
|
|
|
